3-rx.comCustomer Support3-rx.com
Find a product
    HomeAbout UsFAQContactHelp
 
   
 
News Center
Health Centers
Medical Encyclopedia
Drugs & Medications
Diseases & Conditions
Medical Symptoms
Med. Tests & Exams
Surgery & Procedures
Injuries & Wounds
Diet & Nutrition
Special Topics
Online Pharmacy



Type 2 diabetes mellitus, more often known as type 2 diabetes, is the most common type of diabetes


Join our Mailing List

Men`s Health sites at Top100biz.com




Syndicate

You are here : 3-RX.com > Home > AIDS/HIV -

Ingredient in human semen may enhance HIV infection

AIDS/HIVDec 14, 07

An ingredient in human semen may actually help the HIV virus infect cells, German researchers said on Thursday.

They said naturally occurring prostatic acidic phosphatase or PAP, an enzyme produced by the prostate, can form tiny fibers called amyloid fibrils that can capture bits of the human immunodeficiency virus and usher it into cells.

Researchers at the University Clinic of Ulm were looking for factors in semen that might block infection with HIV-1, the most common strain of the virus that causes AIDS.

Instead, they found one that enhanced transmission, in some experiments as much as 50-fold.

“In this study we show that fragments of PAP, a highly abundant semen marker, form amyloid fibrils that drastically enhance the infectiousness of HIV-1,” they wrote in the journal Cell.

They said they are now looking for compounds that might block this process to slow transmission of the disease.

Amyloid fibrils formed from different proteins are associated with many diseases, including Alzheimer’s and prion disease.

“Further studies on the role of amyloids in the transmission and pathogenesis of enveloped viruses are highly warranted,” they wrote.

HIV has infected some 60 million people, killing more than 20 million, the researchers said. More than 90 percent of those infections are acquired through sexual intercourse.

CHICAGO (Reuters)



Print Version
Tell-a-Friend

RELATED ARTICLES:
  Delay in AIDS drug use in South Africa costly
  Protein identified that turns off HIV-fighting T cells
  Study examines repeated exposure to HIV in treatment-suppressed HIV patients
  Markers of inflammation and blood-clotting tied to hazards of intermittent HIV treatment
  What HIV Needs: Identification of Human Factors May Yield Novel Therapeutic Targets for HIV
  HIV Status Unknown for Most “Negative” Men Online
  A Young Woman’s Battle With HIV
  WHO publishes how-to guide on fighting AIDS
  African ex-leaders to press politicians over AIDS
  Mexicans in U.S. illegally at more risk of AIDS
  Government to release revised U.S. HIV estimates
  U.S. drops trial of one AIDS vaccine

 


Advertisement
















Home | About Us | FAQ | Contact | Advertising Policy | Privacy Policy | Bookmark Site